EYPT · EyePoint Inc
United States · RS rating 1 · As of 2026-11-03
| Price | 0.40 USD |
|---|---|
| 1-day change | +8.1% |
| RS rating (overall / 1M / 3M / 12M) | 1 / 1 / 1 / 3 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 20 / 4 / 18 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | +4.7% |
| Sales growth Q/Q | -35.8% |
| Distance from 52-week high | +97.9% |
| Market cap (USD) | $1.2B |